All In MedTech

Device Trial Radar · NCT01634620

Use of FeNO to Identify Eosinophilic Inflammation in Patients Age 40 Years and Above With Chronic Obstructive Airways Disease

Last checked: Nov 19, 2026Latest source record: Feb 12, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

200

Actual

Start

Jun 2012

Primary completion

Oct 2012

Study completion Oct 2012

Sponsor

Lead sponsor
Aerocrine ABNot on our public-company list
Sponsor type
Industry
First posted
Jul 6, 2012

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Objective: To characterize FeNO levels that may be indicative of eosinophilic airway inflammation in patients with chronic obstructive airways disease Number of participants: Approximately 200 subjects will be enrolled Reference product: NIOX MINO® Instrument (09-1100) Performance assessments: Fractional Exhaled Nitric Oxide (FeNO) Measurements will be performed according to the "Perform FeNO Measurement" guidelines on page 7 of the NIOX MINO® User Manual Safety assessments: The Investigator is responsible for the detection, reporting, and documentation of events meeting the definition of an Adverse Event (AE) and/or Serious Injuries as provided in this clinical investigation plan from the time that informed consent has been provided and during the study period Criteria for evaluations: This is an observational, pilot study and there are currently no plans for a formal statistical analysis. Information gained from this study may used to design subsequent studies in patients with chronic obstructive airways disease. Information collected will be summarized in a clinical study report but will not be subject to formal hypothesis testing

Conditions

  • Chronic Obstructive Pulmonary Disease (COPD)

Interventions

  • NIOX MINO® Instrument (09-1100)Device

    FeNO measurements will be performed according to the "Perform FeNO Measurement" guidelines on page 7 of the NIOX MINO® User Manual (February, 2011)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Spirometry Results: FEV1 (L)Time frame: Single Visit
  2. Spirometry Results: FVC (L)Time frame: Single Visit
  3. Spirometry Results: FEV1 (% Predicted)Time frame: Single Visit

8 more outcomes with a free account

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • University of North Carolina Hospitals

    Chapel Hill, North Carolina

  • University of North Carolina Hospitals - Sanford Specialty Clinics

    Sanford, North Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.